醫療影像及報告實作指引
0.1.0 - DSTU0 ci-build
醫療影像及報告實作指引 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Draft as of 2024-03-01 |
{
"resourceType" : "CapabilityStatement",
"id" : "NASH-CapabilityStatement-Client",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li><b>實作指引版本:</b>0.1.0</li><li><b>FHIR版本:</b>4.0.1</li><li><b>發布日:</b>2024-03.01</li><li><b>發布者:</b>CY LAB</li></ul><h3 id=\"igs\" class=\"no_toc\">Client的FHIR RESTful功能要求</h3><h3 id=\"behavior\">Resources或Profiles的RESTful功能</h3><li>Profile</li><ul><li>必須<strong>(SHALL)</strong><code>create</code>、<code>update</code></li></ul><li>共有四類<strong>Resources</strong>,如表列:</li><table class=\"grid\"><thead><tr><th>Resources型別 Type</th><th>Profile</th><th>支援的Profiles</th></tr></thead><tbody><tr><td><span style=\"white-space: nowrap;\">DiagnosticReport<span title=\"SHALL\"/></span></td><td><a href=\"StructureDefinition-NASH-DiagnosticReport.html\"><span style=\"white-space: nowrap;\">診斷報告(DiagnosticReport)<span title=\"SHALL\"/></span></a></td><td><span style=\"white-space: nowrap;\">-<span title=\"SHALL\"/></span></td></tr><tr><td><span style=\"white-space: nowrap;\">ImagingStudy<span title=\"SHALL\"/></span></td><td><a href=\"StructureDefinition-ImagingStudyBase.html\"><span style=\"white-space: nowrap;\">醫學影像(ImagingStudy)<span title=\"SHALL\"/></span></a></td><td><span style=\"white-space: nowrap;\">-<span title=\"SHALL\"/></span></td></tr><tr><td><span style=\"white-space: nowrap;\">Observation<span title=\"SHALL\"/></span></td><td><p><a href=\"StructureDefinition-Observation-NASH-Total-tumor-size.html\"><span style=\"white-space: nowrap;\">巨觀描述(Gross Finding),<span title=\"SHALL\"/></span></a> <a href=\"StructureDefinition-Observation-NASH-Brunt-Scoring-System.html\"><span style=\"white-space: nowrap;\">Brunt評分系統(Brunt Scoring System),<span title=\"SHALL\"/></span></a></p><p><a href=\"StructureDefinition-Observation-NASH-Necroinflammatory-Grading.html\"><span style=\"white-space: nowrap;\">壞死性炎症分級(Necroinflammatory Grading),<span title=\"SHALL\"/></span></a> <a href=\"StructureDefinition-Observation-NASH-Fibrosis-Staging.html\"><span style=\"white-space: nowrap;\">纖維化分期(Fibrosis Staging),<span title=\"SHALL\"/></span></a></p><p><a href=\"StructureDefinition-Observation-NASH-CRN-Scoring-System.html\"><span style=\"white-space: nowrap;\">CRN評分系統(CRN Scoring System),<span title=\"SHALL\"/></span></a> <a href=\"StructureDefinition-Observation-NASH-Steatosis.html\"><span style=\"white-space: nowrap;\">脂肪變性(Steatosis),<span title=\"SHALL\"/></span></a></p><p><a href=\"StructureDefinition-Observation-NASH-Lobular-Inflammation.html\"><span style=\"white-space: nowrap;\">肝小葉發炎(Lobular Inflammation),<span title=\"SHALL\"/></span></a> <a href=\"StructureDefinition-Observation-NASH-Ballooning.html\"><span style=\"white-space: nowrap;\">肝細胞膨脹(Ballooning),<span title=\"SHALL\"/></span></a></p><p><a href=\"StructureDefinition-Observation-NASH-Fibrosis-Stage.html\"><span style=\"white-space: nowrap;\">纖維化分期(Fibrosis Stage),<span title=\"SHALL\"/></span></a> <a href=\"StructureDefinition-Observation-NASH-Knodell-Score-System.html\"><span style=\"white-space: nowrap;\">Knodell評分系統(Knodell Score System),<span title=\"SHALL\"/></span></a></p><p><a href=\"StructureDefinition-Observation-NASH-Periportal-Bridging-Necrosis.html\"><span style=\"white-space: nowrap;\">門脈區橋連壞死(Periportal Bridging Necrosis),<span title=\"SHALL\"/></span></a> <a href=\"StructureDefinition-Observation-NASH-Intralobular-Degeneration-Necrosis.html\"><span style=\"white-space: nowrap;\">小葉內變性壞死(Intralobular Degeneration Necrosis),<span title=\"SHALL\"/></span></a></p><p><a href=\"StructureDefinition-Observation-NASH-Portal-Inflammation.html\"><span style=\"white-space: nowrap;\">門脈炎症(Portal Inflammation),<span title=\"SHALL\"/></span></a> <a href=\"StructureDefinition-Observation-NASH-Fibrosis.html\"><span style=\"white-space: nowrap;\">纖維化(Fibrosis),<span title=\"SHALL\"/></span></a></p><p><a href=\"StructureDefinition-Observation-NASH-Metavir-Fibrosis-Score.html\"><span style=\"white-space: nowrap;\">Metavir纖維化評分(Metavir Fibrosis Score)<span title=\"SHALL\"/></span></a></p></td><td><span style=\"white-space: nowrap;\">-<span title=\"SHALL\"/></span></td></tr><tr><td><span style=\"white-space: nowrap;\">Specimen<span title=\"SHALL\"/></span></td><td><a href=\"StructureDefinition-TWCoreSpecimen.html\"><span style=\"white-space: nowrap;\">檢驗檢體(Specimen)<span title=\"SHALL\"/></span></a></td><td><span style=\"white-space: nowrap;\">-<span title=\"SHALL\"/></span></td></tr></tbody></table></div>"
},
"url" : "https://hapi.fhir.tw/fhir/CapabilityStatement/NASH-CapabilityStatement-Client",
"version" : "0.1.0",
"name" : "NASH_CapabilityStatement",
"title" : "NASH CapabilityStatement",
"status" : "draft",
"experimental" : false,
"date" : "2024-03-01",
"publisher" : "CYLAB",
"description" : "非酒精性脂肪肝(NASH)用戶端(Client)之能力聲明",
"kind" : "requirements",
"fhirVersion" : "4.0.1",
"format" : [
"xml",
"json"
],
"patchFormat" : [
"application/json-patch+json"
],
"implementationGuide" : [
🔗 "https://hapi.fhir.tw/fhir/ImplementationGuide/fhir.PATHIMG"
],
"rest" : [
{
"mode" : "client",
"documentation" : "伺服端(Server) 必須 (SHALL):\n1. 可透過FHIR RESTful API查詢的Resources\n2. 根據FHIR規範實作RESTful\n3. HTTP回傳狀態碼:- (Status 400):無效參數(invalid parameter)\n - (Status 401/4xx):未經授權的請求(unauthorized request)\n - (Status 403):未充分授權的資料存取範圍(insufficient premission scope)\n - (Status 404):未知的resource(unknown resource)\n 4. Server提供的API操作皆支援JSON格式\n\n伺服端(Server) 建議應該(SHOULD):\n1. Server提供的API操作皆支援XML格式\n2. 可識別每個新增到Server的實例(instance)之 meta.profile是否為Profiles Defining URL,並確認實例是否依循profile製作。【註:實例是指依據profile實作,將真實資料以JSON、XML或Turtle格式存放的檔案】\n3. 支援每個profile的查詢參數\n\n安全性:Server必須(SHALL)透過回傳 HTTP 401「未授權」, HTTP 403「禁止」,或 HTTP 404 「未找到」,來拒絕任何未經授權的請求\n\n系統互動能力:- 可能可以(MAY)支援交易(transaction)\n - 可能可以(MAY)支援批次(batch)\n - 可能可以(MAY)支援查詢系統(search-system)"
}
]
}